SEC Form 10-K filed by Kintara Therapeutics Inc.
$KTRA
Biotechnology: Pharmaceutical Preparations
Health Care
Unavailable
Unavailable
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
1/20/2022 | $6.00 → $3.00 | Buy | HC Wainwright & Co. |
9/30/2021 | $7.00 → $5.00 | Buy | Aegis Capital |
9/28/2021 | $6.00 | Buy | HC Wainwright & Co. |